Xarelto and Meibomian gland dysfunction - from FDA reports


Summary

Meibomian gland dysfunction is reported only by a few people who take Xarelto. We study 87,540 people who have side effects while taking Xarelto from FDA. Among them, 1 have Meibomian gland dysfunction. Find out below who they are, when they have Meibomian gland dysfunction and more.

What to expect?

If you take Xarelto and have Meibomian gland dysfunction, find out what symptoms you could have in 1 year or longer.

You are not alone!

Join a support group for people who take Xarelto and have Meibomian gland dysfunction

Personalized health information

On eHealthMe you can find out what patients like me (same gender, age) reported their drugs and conditions on FDA since 1977. Our tools are simple to use, anonymous and free. Start now >>>

On Nov, 17, 2017

87,540 people reported to have side effects when taking Xarelto.
Among them, 1 person (0.0%) has Meibomian gland dysfunction


Number of reports submitted per year:

Could Xarelto cause Meibomian gland dysfunction?

Gender of people who have Meibomian gland dysfunction when taking Xarelto *:

  • female: 100 %
  • male: 0.0 %

Top conditions involved for these people *:

  • Multiple Myeloma (1 person, 100.00%)

Top co-used drugs for these people *:

  • Revlimid (1 person, 100.00%)
  • Ondansetron (1 person, 100.00%)
  • Lotemax (1 person, 100.00%)
  • Blephamide (1 person, 100.00%)

Top other side effects for these people *:

  • Oedema Peripheral (1 person, 100.00%)
  • Dacryostenosis Acquired (1 person, 100.00%)
  • Blepharitis (1 person, 100.00%)

* Approximation only. Some reports may have incomplete information.

How to use the study: print a copy of the study and bring it to your health teams to ensure drug risks and benefits are fully discussed and understood.

Subscribe to the study: get notified of updates to the study.

Do you have Meibomian gland dysfunction when taking Xarelto?

Expand the study to include all drugs with the same ingredients

Meibomian gland dysfunction and drugs with ingredients of rivaroxaban.

Expand the study to include reports from both FDA and eHealthMe

Meibomian gland dysfunction and Xarelto from FDA and eHealthMe reports

Xarelto

Xarelto has active ingredients of rivaroxaban. It is often used in atrial fibrillation/flutter. (latest outcomes from Xarelto 88,586 users)

Meibomian gland dysfunction

Meibomian gland dysfunction (dry eyes) has been reported by people with osteoporosis, glaucoma, diabetic retinal oedema, dry eyes, high blood pressure (latest reports from 117 Meibomian gland dysfunction patients).

Browse all side effects of Xarelto

a b c d e f g h i j k l m n o p q r s t u v w x y z

Drugs that are associated with Meibomian gland dysfunction

Meibomian gland dysfunction

Could your condition cause Meibomian gland dysfunction

Meibomian gland dysfunction

Related studies

What would happen?

Forecast new side effects and undetected conditions when you take Xarelto and have Meibomian gland dysfunction.

Questions to the study

More questions >

User reviews to the study

More reviews >